1. Pink Sheet

PhRMA Promotes Cluster Concept In Japan Reform Wish List

Holistic Changes Needed, US Group Says

 
• By Ian Haydock

US industry association promotes an exchanges with Japan on bioclusters, while continuing to push for holistic debate on reforms to the country’s national healthcare system and changes to reimbursement pricing it sees as supporting innovation.

wish list of policy change for pharma has become longer recently
US innovator group lists Japan reform items • Source: Shutterstock

The US research-based industry group The Pharmaceutical and Research Manufacturers of America (PhRMA) is continuing to advocate for broad debate around reforms to Japan’s healthcare and drug reimbursement pricing systems, as it seeks to create an environment it sees as conducive to sustainable innovation, patient access to new drugs and economic benefits.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

More from Asia